InvestorsHub Logo
Followers 39
Posts 2694
Boards Moderated 0
Alias Born 02/08/2014

Re: WeeZuhl post# 380236

Sunday, 05/14/2023 10:28:01 AM

Sunday, May 14, 2023 10:28:01 AM

Post# of 401576
The way I read Nasrat's input on this in the last CC is that it was supposed to be available in April. I can find it available to buy so there must be enough to keep customers afloat for awhile. I think it will be easy for Elite to convince pharmacies to buy their Adderall and Isradipine because they are crucial products for Elite. Teva doesn't really care if it loses a few dollars from Isradipine (they didn't even bother to explain why they were behind).

From last CC:

Isradipine and trumapramine will be sold under Elite's label as well as of April. Although modest in size, both products have only one or two competitors, therefore, the margins can be attractive. We believe that being directly involved in pricing will help Elite to increase the value of these products. Loxapine and Dantrolene will also be offered as of April 1 and under Elite's label.



Blurb about when Teva would have more from notice WeeZuhl referenced

Teva has isradipine 2.5 mg and 5 mg capsules in 100 count bottles on back order and the company estimates a release date in late-July 2023 for the 2.5 mg capsules and late-June for the 5 mg capsules.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News